It was a fairly tough day in the markets for investors in Better Therapeutics (NASDAQ:BTTX) as the company saw its shares tank by as much as 5% for the day after making an announcement with regards to its first quarter financial results.
Trading Data
On Tuesday, BTTX stock went down 4.57% to $2.09 with more than 8.05 million shares, compared to its average volume of 5.67 million shares. The stock moved within a range of $1.9000 – 2.4299 after opening trade at $2.24.
Key Details
The company announced yesterday that it was going to announce its financial results for the first fiscal quarter of 2022 on May 13. It was also noted that the results were going to be released before the opening of the markets on the day. However, that was not all. It was also announced that the company’s management was going to host a conference call on the same day at 8:30 in the morning Eastern Time.
Both domestic and international audiences could dial in to the conference call. In addition to that, a live webcast of the same is also going to be made available online.
Last month the company had been in focus after it announced on April 6 that it had hit some major milestones with regards to further validation of the therapeutic technologies that it had been working on. It now remains to be seen if the Better Therapeutics stock gets any traction in the days leading up to May 13.
Technical Data
BTTX stock is above the 20-Day and 50-Day Moving averages of $1.77 and $2.09 respectively. However, the stock is trading below the 200-Day moving average of $6.26.
